← back to search

Mingwei Chen

Anhui Medical University · CN
Area of research
Pulmonary and Respiratory Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Sputum and Cancer research, with related work in Burden of disease, MG132, Protein kinase B. Notable publications include 'Global PM2.5-attributable health burden from 1990 to 2017: Estimates from the Global Burden of disease study 2017', 'The E3 ubiquitin ligases β-TrCP and FBXW7 cooperatively mediates GSK3-dependent Mcl-1 degradation induced by the Akt inhibitor API-1, resulting in apoptosis', and 'Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study'.
h-index
citations
468
works
6
NIH funding
primary concept
email

Recent publications

Highly diverse sputum microbiota correlates with the disease severity in patients with community-acquired pneumonia: a longitudinal cohort study
Respiratory Research 2024cited by 18position: middledoi
Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study
BMC Infectious Diseases 2023cited by 48position: middledoi
High blood urea nitrogen to creatinine ratio is associated with increased risk of sarcopenia in patients with chronic obstructive pulmonary disease
Experimental Gerontology 2022cited by 32position: lastdoi
Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015–2017): A multicentre prospective study
The Lancet Regional Health - Western Pacific 2022cited by 11position: middledoi
Cost-effectiveness of lung cancer screening combined with nurse-led smoking cessation intervention: A population-based microsimulation study
International Journal of Nursing Studies 2022cited by 10position: middledoi
The mediating role of decision-making conflict in the association between patient’s participation satisfaction and distress during medical decision-making among Chinese patients with pulmonary nodules
Patient Education and Counseling 2022cited by 4position: middledoi
Global PM2.5-attributable health burden from 1990 to 2017: Estimates from the Global Burden of disease study 2017
Environmental Research 2021cited by 280position: middledoi
EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non‑small cell lung cancer cells
Oncology Reports 2021cited by 13position: lastdoi
The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database
Current Problems in Cancer 2020cited by 6position: lastdoi
mTORC2 Suppresses GSK3-Dependent Snail Degradation to Positively Regulate Cancer Cell Invasion and Metastasis
Cancer Research 2019cited by 38position: middledoi
Association of ACYP2 and TSPYL6 Genetic Polymorphisms with Risk of Ischemic Stroke in Han Chinese Population
Molecular Neurobiology 2016cited by 16position: lastdoi
The E3 ubiquitin ligases β-TrCP and FBXW7 cooperatively mediates GSK3-dependent Mcl-1 degradation induced by the Akt inhibitor API-1, resulting in apoptosis
Molecular Cancer 2013cited by 73position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hui Ren · Union Hospital4 papers (2013–2022)Xiang Bu · Shanxi Medical University3 papers (2020–2022)Puyu Shi · Dalian Medical University2 papers (2016–2021)Xiqiang Wang · Ministry of Education of the People's Republic of China2 papers (2020–2021) · 2 papers (2022–2022)Shi‐Yong Sun · Emory University2 papers (2013–2019)Linyan Wei · Ministry of Education of the People's Republic of China2 papers (2020–2021)Jing Liu · First Affiliated Hospital of Xi'an Jiaotong University2 papers (2020–2021)Yiqian Liang · Shanxi Medical University2 papers (2016–2021)Yan Sun · South China Agricultural University2 papers (2022–2022)Shuo Zhang · North China University of Science and Technology2 papers (2016–2021)Jing Wang · ETH Zurich1 papers (2022–2022)Zhonglei Xie · Jilin Medical University1 papers (2021–2021)Jianping Xu · Hebei General Hospital1 papers (2022–2022)Yan Xiao · Roche (United States)1 papers (2024–2024) · 1 papers (2022–2022) · 1 papers (2022–2022)Xingming Deng · Emory University1 papers (2013–2013)Xiaohua Hu · Guangxi Medical University1 papers (2022–2022)Hui Ren · Union Hospital1 papers (2021–2021)